Company Filing History:
Years Active: 2014
Title: Yigang He: Innovator in Pain Treatment and Oligonucleotide Synthesis
Introduction
Yigang He is a notable inventor based in Ewing, NJ, with a focus on developing innovative compounds for medical applications. He holds two patents that showcase his contributions to the fields of pain management and oligonucleotide synthesis. His work reflects a commitment to advancing scientific knowledge and improving patient care.
Latest Patents
Yigang He's latest patents include novel aminoindane compounds and methods for treating pain. The first patent provides a detailed description of these compounds and their utility in alleviating pain and itch in patients. The methods involve administering a compound alongside a TRPV1 receptor activator, such as lidocaine, to enhance therapeutic effects. The second patent outlines a method for synthesizing oligonucleotides using N-thio compounds. This method involves a sulfurizing agent that modifies phosphorus internucleotide linkages, ultimately leading to the purification of the oligonucleotide.
Career Highlights
Throughout his career, Yigang He has worked with reputable companies, including Asana Biosciences, LLC and Girindus America, Inc. His experience in these organizations has allowed him to contribute significantly to research and development in the pharmaceutical industry.
Collaborations
Yigang He has collaborated with professionals such as Scott Kevin Thompson and Tony Priestley. These partnerships have likely enriched his research endeavors and fostered innovation in his projects.
Conclusion
Yigang He is a distinguished inventor whose work in aminoindane compounds and oligonucleotide synthesis has the potential to make a significant impact in medical treatments. His contributions reflect a dedication to advancing science and improving patient outcomes.